Abstract: This article investigates the ultimately bounded proportional–integral–derivative (PID) control problem for a class of discrete-time Takagi–Sugeno fuzzy systems subject to ...
Abstract: This paper concerns ultimately bounded output-feedback control problems for networked systems with unknown nonlinear dynamics. Sensor-to-observer signal transmission is facilitated over ...
Albertans may see more and less-expensive varieties of Ozempic on the market soon, after a patent on the drug expired two weeks ago. Ozempic has made headlines in recent years as a popular weight-loss ...
In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...
The generic product is now available nationwide in strengths of 0.3mg, 0.45mg, 0.625mg, 0.9mg, and 1.25mg. The Food and Drug Administration (FDA) has approved the first generic version of Premarin ® ...
The Food and Drug Administration said it will take steps to speed up the process of developing generic versions of complex biological drugs, in a bid to increase cheaper competition for expensive ...
Share on Pinterest The FDA recently approved a generic abortion pill that’s considered as safe and effective as mifepristone. Shuran Huang for The Washington Post via Getty Images The approval, ...
A U.S. federal judge rejected Novartis' efforts to block the launch of a generic version of Entresto, its blockbuster cardiovascular disease drug, per a FirstWord PHARMA report. The report noted that ...
Everywhere you look, people are talking about AI agents like they’re just a prompt away from replacing entire departments. The dream is seductive: Autonomous systems that can handle anything you throw ...
Apotex has launched the first generic version of Tasigna ® (nilotinib capsules). Nilotinib is a kinase inhibitor indicated for the treatment of adult and pediatric patients aged 1 year and older with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results